Deep Track Capital, LP Portfolio Holdings

Deep Track Capital, LP

  • $2.82 Billion
  • Q2 2025

Deep Track Capital, LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $2.82 Billion distributed in 66 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Immunovant, Inc. with a value of $261M, Guardant Health, Inc. with a value of $221M, Ionis Pharmaceuticals Inc with a value of $193M, Protagonist Therapeutics, Inc with a value of $179M, and Dynavax Technologies Corp with a value of $176M.

Examining the 13F form we can see an decrease of $41.4M in the current position value, from $2.86B to 2.82B.

Deep Track Capital, LP is based out at Greenwich, CT

Below you can find more details about Deep Track Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $2.82 Billion
Healthcare: $2.82 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.55B
$261 Million 9.27% of portfolio
9,500,000
Q1 2025 Added 58.33%
$5.63B
$221 Million 7.85% of portfolio
4,250,000
Q2 2025 Reduced 21.93%
$5.85B
$193 Million 6.86% of portfolio
4,891,544
Q2 2025 Added 7.17%
$2.68B
$179 Million 6.36% of portfolio
3,245,899
Q2 2025 Added 8.2%
$1.34B
$176 Million 6.26% of portfolio
17,791,486
Q4 2024 Added 42.03%
$16.5B
$176 Million 6.25% of portfolio
1,750,000
Q2 2025 Added 586.95%
$2.23B
$162 Million 5.76% of portfolio
3,042,598
Q2 2025 Reduced 5.22%
$961M
$133 Million 4.71% of portfolio
14,294,420
Q1 2025 Added 11.36%
$2.63B
$121 Million 4.3% of portfolio
7,000,000
Q2 2025 Added 40.0%
$3.23B
$121 Million 4.28% of portfolio
3,650,000
Q2 2025 Added 18.74%
$420M
$93.3 Million 3.31% of portfolio
9,500,000
Q2 2025 Added 1.97%
$4.51B
$83.7 Million 2.97% of portfolio
801,371
Q2 2025 New
$363M
$75.4 Million 2.68% of portfolio
8,831,007
Q2 2025 Reduced 0.32%
$717M
$75.2 Million 2.67% of portfolio
5,380,449
Q1 2025 Added 18.96%
$1.37B
$70.9 Million 2.51% of portfolio
1,750,000
Q2 2025 Added 17.9%
$1.78B
$69.9 Million 2.48% of portfolio
2,150,000
Q2 2025 Added 186.67%
$510M
$60.6 Million 2.15% of portfolio
43,000,000
Q2 2025 Added 12.64%
$1.4B
$56.5 Million 2.0% of portfolio
1,800,000
Q2 2025 Added 27.53%
$1.97B
$49.1 Million 1.74% of portfolio
1,350,000
Q1 2025 Added 106.58%
$1.54B
$45.7 Million 1.62% of portfolio
700,000
Q1 2025 Added 7.85%
$2.24B
$42.3 Million 1.5% of portfolio
1,350,000
Q2 2025 Added 35.0%
$1.11B
$40.7 Million 1.44% of portfolio
2,000,000
Q1 2025 Added 29.86%
$7.28B
$38.9 Million 1.38% of portfolio
900,000
Q2 2025 Reduced 67.86%
$195M
$38.4 Million 1.36% of portfolio
16,852,147
Q2 2025 Reduced 5.59%
$505M
$28.4 Million 1.01% of portfolio
8,585,980
Q2 2025 Reduced 11.69%
$246M
$28 Million 0.99% of portfolio
7,495,000
Q2 2025 Added 34.4%
$632M
$24.4 Million 0.86% of portfolio
2,000,000
Q1 2025 New
$215M
$14.7 Million 0.52% of portfolio
3,442,833
Q4 2024 Reduced 13.93%
$2.93B
$14.5 Million 0.51% of portfolio
275,000
Q2 2025 New
$214M
$8.36 Million 0.3% of portfolio
1,203,244
Q2 2025 Added 56.87%
$1.61B
$6.57 Million 0.23% of portfolio
500,000
Q2 2025 New
$663M
$6.29 Million 0.22% of portfolio
998,542
Q2 2025 Reduced 34.23%
$10.9M
$4.9 Million 0.17% of portfolio
7,419,355
Q2 2024 New
$1.6B
$4.44 Million 0.16% of portfolio
259,800
Q2 2025 Reduced 71.12%
$81.8M
$4.58 Million 0.16% of portfolio
3,947,807
Q2 2025 Reduced 26.89%
$463M
$4.32 Million 0.15% of portfolio
549,439
Q1 2025 Added 9.89%
$109M
$4.27 Million 0.15% of portfolio
1,040,115
Q4 2024 Reduced 52.05%
$50M
$3.37 Million 0.12% of portfolio
2,515,513
Q1 2025 New
Rapt Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
Septerna Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 93.64%
Spyre Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 78.1%
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 25.22%
Abivax Sa
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 2.77%
Tectonic Therapeutic Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Aligos Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 81.93%
Bicara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 21.33%
Upstream Bio Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 37.26%
Avalo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 34.05%
Rapport Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 78.53%

Summary

  • Portfolio
  • No. of Stocks 66
  • Current Value $2.82 Billion
  • Prior Value $2.86 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 7 stocks
  • Additional Purchases 18 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 20 stocks
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email